What AI Companies Get Wrong About Curing Cancer (with Emilia Javorsky)

Emilia Javorsky is a physician-scientist and Director of the Futures Program at the Future of Life Institute. She joins the podcast to discuss her newly published essay on AI and cancer. She challenges tech claims that superintelligence will cure cancer, explaining why biology’s complexity, poor data, and misaligned incentives are bigger bottlenecks than raw intelligence. The conversation covers realistic roles for AI in drug discovery, clinical trials, and cutting unnecessary medical bureaucracy. You can read the full essay at: curecancer.ai CHAPTERS: (00:00) Episode Preview (01:10) Introduction and essay motivation (06:30) Intelligence vs data bottlenecks (19:03) Cancer's complexity and heterogeneity (29:05) Measurement, health, and homeostasis (41:41) AI in drug development (50:13) Regulation, FDA, and innovation (01:02:58) Practical paths toward cures PRODUCED BY: SOCIAL LINKS: Website: Twitter (FLI): Twitter (Gus): LinkedIn: YouTube: Apple: Spotify:

You can listen to What AI Companies Get Wrong About Curing Cancer (with Emilia Javorsky) online on Radio and Podcast. Open the player on this page to stream the available audio.

What AI Companies Get Wrong About Curing Cancer (with Emilia Javorsky) is an episode from Future of Life Institute Podcast by Gus Docker.

This episode is 72:10 long.

This episode was published on Mar 20, 2026.

Yes. Use the heart button on the episode page to add it to your favorite episodes list.

Yes. This page shows related episodes from Future of Life Institute Podcast when more episodes are available from the podcast feed.